查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1875954

全球多重免疫檢測分析市場

Multiplex Detection Immunoassays
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年，全球多重免疫檢測市場規模將達35億美元。

2024年全球多重檢測免疫檢測市場規模預計為29億美元，預計到2030年將達35億美元，在分析期（2024-2030年）內複合年成長率（CAGR）為3.4%。本報告分析的細分市場之一—基於蛋白質的多重檢測技術，預計將以3.6%的複合年成長率成長，並在分析期結束時達到24億美元。基於核酸的多重檢測技術細分市場預計在分析期間內將以3.2%的複合年成長率成長。

美國市場規模估計為7.651億美元，而中國市場預計將以3.3%的複合年成長率成長。

預計2024年，美國多重免疫檢測市場規模將達7.651億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到5.64億美元，在2024年至2030年的分析期間內，複合年成長率（CAGR）為3.3%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為3.2%和2.8%。在歐洲，德國的複合年成長率預計約為3.4%。

全球多重檢測免疫檢測市場—關鍵趨勢與促進因素概述

什麼是多重免疫檢測？它的工作原理是什麼？

多重檢測免疫檢測是一種專門的診斷工具，它利用免疫學檢測技術，在單一檢體中同時檢測多種抗原或抗體。這些檢測法利用抗體特異性結合標靶分子，從而實現多種分析物的同步檢測和定量，使其在臨床診斷和研究中都具有極高的應用價值。多重檢測免疫檢測廣泛應用於免疫學、感染疾病和腫瘤學領域，用於監測免疫反應、檢測生物標記和早期疾病診斷。與傳統的單分析檢測法相比，多重檢測免疫分析能夠以極少的檢體提供高通量、詳細的結果，從而顯著提高工作流程效率和診斷準確性。

科技進步如何改變多重檢測免疫檢測？

檢測設計、檢測方法和微流體技術的進步正在迅速提升多重免疫分析的效能。螢光和化學冷光檢測系統的創新顯著提高了這些檢體的靈敏度和特異性，使得在更低濃度下檢測生物標記成為可能。微流體和晶片實驗室技術實現了更緊湊、更有效率的多重分析，在提高通量的同時減少了樣品和試劑的用量。此外，人工智慧驅動的數據分析和自動化平台等數位技術的整合提高了分析結果解讀的速度和準確性。這些進步拓展了多重免疫分析的應用範圍，使其在個人化醫療、疫苗研發、照護現場診斷等領域得到更廣泛的應用。

精準診斷的需求如何推動多重免疫檢測技術的應用？

精準診斷日益受到重視，它能夠根據每位患者獨特的分子特徵提供個人化醫療服務，這推動了多重免疫檢測的應用。這些檢測法使臨床醫生能夠在一次檢測中分析多種疾病標記物，從而更全面地了解患者的健康狀況。例如，在感染疾病診斷中，多重檢測法可以同時檢測多種病原體，提高診斷準確性並加快治療速度。在腫瘤學領域，它們用於監測癌症治療的免疫反應並檢測腫瘤標記。個人化醫療對高效、精細診斷的需求不斷成長，推動了多重檢測免疫檢測在各種醫療應用領域的廣泛應用。

多重免疫檢測市場的主要成長要素是什麼？

多重檢測免疫檢測市場成長受多種因素驅動，包括技術進步、對精準診斷日益成長的需求以及對疾病早期檢測的日益重視。檢測技術和分析方法設計的創新使這些免疫檢測更加靈敏且擴充性，從而促進了其在臨床診斷和研究中的廣泛應用。慢性病和感染疾病（例如癌症和新冠肺炎）的日益流行，推動了對更全面診斷工具的需求，進而促進了多重檢測免疫檢測的應用。此外，個人化醫療的擴展和生物標記發現日益重要，也促進了對這些檢測法的需求，這些方法能夠對疾病狀態和治療反應進行詳細分析。

部分：

依技術（基於蛋白質的多重檢測技術、基於核酸的檢測技術、基於生物感測器的檢測技術）、按應用（疾病檢測、食品污染檢測、藥物研發、獸醫疾病檢測）分類

受訪公司範例

  • BD Biosciences
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Luminex Corporation
  • Microsynth AG
  • MilliporeSigma
  • Qiagen NV
  • Quansys Biosciences
  • Thermo Fisher Scientific, Inc.
  • Unisensor

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，改變您分析市場和競爭情報的方式。

Market Glass, Inc. 並沒有採用查詢LLM 或產業專用的SLM 的典型方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片轉錄、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在地、製造地以及進出口（成品和OEM產品）情況，預測企業競爭地位的變化。這種複雜多變的市場現實會從多個方面影響競爭對手，包括增加銷貨成本、降低盈利和重組供應鏈，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 世界其他地區

第4章 競賽

簡介目錄
Product Code: MCP13508

Global Multiplex Detection Immunoassays Market to Reach US$3.5 Billion by 2030

The global market for Multiplex Detection Immunoassays estimated at US$2.9 Billion in the year 2024, is expected to reach US$3.5 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. Protein-Based Multiplex Technique, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Nucleic Acid Based Technique segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$765.1 Million While China is Forecast to Grow at 3.3% CAGR

The Multiplex Detection Immunoassays market in the U.S. is estimated at US$765.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$564.0 Million by the year 2030 trailing a CAGR of 3.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Multiplex Detection Immunoassays Market - Key Trends & Drivers Summarized

What Are Multiplex Detection Immunoassays and How Do They Work?

Multiplex detection immunoassays are specialized diagnostic tools that allow the simultaneous measurement of multiple antigens or antibodies in a single sample using immunological detection methods. These assays utilize antibodies to specifically bind to target molecules, enabling the detection and quantification of multiple analytes simultaneously, making them invaluable in both clinical diagnostics and research. Multiplex detection immunoassays are widely used in immunology, infectious diseases, and oncology to monitor immune responses, detect biomarkers, and diagnose diseases early. Their ability to provide high-throughput, detailed results from minimal samples offers considerable advantages over traditional single-analyte assays, streamlining workflows and enhancing diagnostic accuracy.

How Are Technological Innovations Transforming Multiplex Detection Immunoassays?

Technological advancements in assay design, detection methods, and microfluidics are rapidly enhancing the performance of multiplex detection immunoassays. Innovations in fluorescent and chemiluminescent detection systems have significantly improved the sensitivity and specificity of these assays, enabling the detection of lower levels of biomarkers. Microfluidics and lab-on-a-chip technologies have also allowed for more compact, efficient multiplex assays, reducing sample and reagent volumes while increasing throughput. Furthermore, the integration of digital technologies, such as AI-driven data analysis and automated platforms, is improving the speed and accuracy of interpreting assay results. These advancements are making multiplex detection immunoassays more versatile, expanding their applications in personalized medicine, vaccine development, and point-of-care diagnostics.

How Is the Demand for Precision Diagnostics Boosting the Use of Multiplex Detection Immunoassays?

The growing emphasis on precision diagnostics, which involves tailoring medical treatment to individual patients based on their unique molecular profiles, is driving the adoption of multiplex detection immunoassays. These assays enable clinicians to analyze multiple disease markers in a single test, providing a more comprehensive understanding of a patient’s health status. In infectious disease diagnostics, for example, multiplex assays allow for the simultaneous detection of multiple pathogens, improving diagnostic accuracy and treatment speed. In oncology, these assays are being used to monitor immune responses to cancer therapies and detect tumor markers. The demand for more efficient and detailed diagnostics in personalized medicine is fueling the growth of multiplex detection immunoassays across various healthcare applications.

What Are the Key Growth Drivers in the Multiplex Detection Immunoassays Market?

The growth in the multiplex detection immunoassays market is driven by several factors, including technological advancements, the increasing demand for precision diagnostics, and the growing focus on early disease detection. Innovations in detection technologies and assay design are making these immunoassays more sensitive and scalable, allowing for broader adoption in clinical diagnostics and research. The rising prevalence of chronic and infectious diseases, such as cancer and COVID-19, is pushing the need for more comprehensive diagnostic tools, driving the use of multiplex detection immunoassays. Additionally, the expansion of personalized medicine and the growing importance of biomarker discovery are contributing to the demand for these assays, as they allow for more detailed analysis of disease states and treatment responses.

SCOPE OF STUDY:

The report analyzes the Multiplex Detection Immunoassays market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technique (Protein-Based Multiplex Technique, Nucleic Acid Based Technique, Biosensor Based Technique); Application (Disease Testing, Food Contamination Testing, Drug Development, Veterinary Disease Testing)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 14 Featured) -

  • BD Biosciences
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Luminex Corporation
  • Microsynth AG
  • MilliporeSigma
  • Qiagen NV
  • Quansys Biosciences
  • Thermo Fisher Scientific, Inc.
  • Unisensor

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Multiplex Detection Immunoassays - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for High-Throughput Diagnostic Testing Propels Growth in Multiplex Detection Immunoassays
    • Increasing Prevalence of Infectious Diseases Expands Addressable Market for Multiplex Detection Immunoassays
    • Growing Focus on Personalized Medicine Strengthens Business Case for Multiplex Detection Immunoassays in Biomarker Discovery
    • Technological Advancements in Immunoassay Platforms Propel Innovation in Multiplex Detection Systems
    • Surge in Oncology Research Drives Adoption of Multiplex Detection Immunoassays in Cancer Diagnostics
    • Increasing Use of Multiplex Detection Immunoassays in Vaccine Development Expands Opportunities in Pandemic Response
    • Growth in Point-of-Care Diagnostics Drives Demand for Rapid and Portable Multiplex Immunoassay Kits
    • Rising Importance of Immunotherapy Expands Market for Multiplex Detection Immunoassays in Immunology
    • Increasing Focus on Reducing Healthcare Costs Fuels Demand for Cost-Effective Multiplex Testing Solutions
    • Expansion of Companion Diagnostics in Targeted Therapies Drives Market for Multiplex Detection Immunoassays
    • Technological Advancements in Microfluidics and Lab-on-a-Chip Platforms Propel
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Food Contamination Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Food Contamination Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Food Contamination Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Veterinary Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Veterinary Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Veterinary Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Protein-Based Multiplex Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Protein-Based Multiplex Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Protein-Based Multiplex Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Nucleic Acid Based Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Nucleic Acid Based Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Nucleic Acid Based Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Biosensor Based Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Biosensor Based Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Biosensor Based Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Multiplex Detection Immunoassays Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Multiplex Detection Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Multiplex Detection Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • JAPAN
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • CHINA
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • EUROPE
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Multiplex Detection Immunoassays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Multiplex Detection Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • GERMANY
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Europe 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Multiplex Detection Immunoassays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Asia-Pacific 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Multiplex Detection Immunoassays by Application - Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of World 15-Year Perspective for Multiplex Detection Immunoassays by Application - Percentage Breakdown of Value Sales for Disease Testing, Food Contamination Testing, Drug Development and Veterinary Disease Testing for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Multiplex Detection Immunoassays by Technique - Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of World 15-Year Perspective for Multiplex Detection Immunoassays by Technique - Percentage Breakdown of Value Sales for Protein-Based Multiplex Technique, Nucleic Acid Based Technique and Biosensor Based Technique for the Years 2015, 2025 & 2030

IV. COMPETITION